Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE
Sign Up
Log in

Creo Medical Group PLC
LSE:CREO

Watchlist Manager
Creo Medical Group PLC Logo
Creo Medical Group PLC
LSE:CREO
Watchlist
Price: 12.625 GBX -2.88% Market Closed
Market Cap: £52.1m
Write Note Create Alert Ask AI

Intrinsic Value

The intrinsic value for Creo Medical Group PLC (CREO) under the Base Case is 1.811 GBX. Compared with the current market price of 12.625 GBX, the stock appears Overvalued by 86% .

Based on two methods:
DCF Value
N/A
Multiples-Based Value
GBX1.811
DCF Value
N/A
Multiples-Based Value
GBX1.811
CREO Intrinsic Value
1.811 GBX
Overvaluation 86%
Intrinsic Value
Price GBX12.625
Bear Case
Base Case
Bull Case
Monitor CREO
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value GBX1.45
Get notified when the price drops into your buy zone
Current Price GBX12.63
Intrinsic Value GBX1.81
Margin of Safety 20% GBX1.45
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
What is Valuation History?
Ask AI Assistant
What other research platforms think about CREO?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CREO valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Creo Medical Group PLC.

Explain Valuation
Alternatives to CREO

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Creo Medical Group PLC

Wall St Price Targets

Capital Returns

Competitive Landscape

See Also

Summary
CREO intrinsic value, competitors valuation, and company profile.
DCF Valuation
CREO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CREO stock valuation using valuation multiples.
Wall St Estimates
CREO price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CREO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Creo Medical Group PLC listings:
F • EUR
1RC
Discover More
What is the Intrinsic Value of one CREO stock?

The intrinsic value for Creo Medical Group PLC (CREO) under the Base Case is 1.811 GBX.

Is CREO stock undervalued or overvalued?

Compared with the current market price of 12.625 GBX, the stock appears Overvalued by 86% .

Back to Top
ALPHA SPREAD
Follow us
Join 334,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett